Page 3 - Si Bone News Today

Many investors define successful investing as beating the market average over the long term. But its virtually certain...

SANTA CLARA, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal...

SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) CFO Anshul Maheshwari sold 1,244 shares of the firm’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $21.15, for a total transaction of $26,310.60. Following the transaction, the chief financial officer now directly owns 150,471 shares of the company’s […]

SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) insider Anthony J. Recupero sold 1,712 shares of the firm’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $21.16, for a total transaction of $36,225.92. Following the transaction, the insider now directly owns 209,296 shares of the company’s stock, […]

SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) has been given an average rating of “Buy” by the seven brokerages that are covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 1 year target price among brokers that have issued ratings on the stock in the last […]

SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) saw a significant drop in short interest in August. As of August 31st, there was short interest totalling 742,500 shares, a drop of 22.3% from the August 15th total of 955,900 shares. Based on an average daily trading volume, of 375,000 shares, the days-to-cover ratio is presently 2.0 […]

Royce & Associates LP grew its position in shares of SI-BONE, Inc. (NASDAQ:SIBN – Free Report) by 37.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 132,000 shares of the company’s stock after acquiring an additional 36,000 shares […]

SI-Bones iFuse Bedrock Granite spine implants are compatible with certain CD Horizon Solera 5.5mm and 6.0mm rods from Medtronic, according to a Sept. 6 news release. 

Cantor Fitzgerald restated their overweight rating on shares of SI-BONE (NASDAQ:SIBN – Free Report) in a research report released on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $30.00 price target on the stock. Several other equities analysts have also recently issued reports on the company. Needham & Company LLC reissued a buy rating and […]

Shares of SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) have been given a consensus recommendation of “Buy” by the seven ratings firms that are presently covering the company, Marketbeat reports. Seven investment analysts have rated the stock with a buy rating. The average twelve-month price objective among brokers that have issued a report on the […]